(MedPage Today) — Program distributed $664 million in 2012
Neuromyelitis optica: conventional therapies do not achieve the best results
In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous…
VIDEO: Subretinal fluid seen as ‘protective’ against development of macular atrophy
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Brandon G. Busbee, MD, reports on risk factors associated with development of macular atrophy as determined by 2-year ad hoc findings from the HARBOR trial, in which the presence of subretinal fluid in the baseline population “seemed to be protective” against development of macular atrophy.
Research and Markets: Global Ocular Hypertension Pipeline Review H2 2015 – 17 Companies & 27 Drug Profiles
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/h4zm8f/ocular) has announced the addition of the “Ocular Hypertension – Pipeline Review, H2 2015” report to their offering.This report provides comprehensive info…
Halteres, essential for flight in all flies, are needed by some to climb walls
Sensory organ use hints at how brain processes multiple sources of information.
Stem cell study paves the way for patient therapies
Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic make-up suggests.